Q4 EPS Estimates for HealthEquity Decreased by Analyst

HealthEquity, Inc. (NASDAQ:HQY) – Investment analysts at Barrington Research cut their Q4 2026 earnings per share (EPS) estimates for shares of HealthEquity in a research note issued on Wednesday, September 3rd. Barrington Research analyst A. Paris now forecasts that the company will earn $0.76 per share for the quarter, down from their prior forecast of $0.78. Barrington Research has a “Outperform” rating and a $125.00 price objective on the stock. The consensus estimate for HealthEquity’s current full-year earnings is $2.32 per share.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.81 by $0.16. The firm had revenue of $330.80 million during the quarter, compared to the consensus estimate of $322.25 million. HealthEquity had a return on equity of 12.04% and a net margin of 11.49%.During the same quarter in the prior year, the company earned $0.80 EPS.

Other research analysts also recently issued research reports about the company. JMP Securities upped their price objective on HealthEquity from $110.00 to $117.00 and gave the company a “market outperform” rating in a research note on Wednesday, June 4th. Deutsche Bank Aktiengesellschaft lifted their price objective on HealthEquity from $98.00 to $115.00 and gave the stock a “buy” rating in a report on Thursday, June 5th. Raymond James Financial reissued a “strong-buy” rating and issued a $120.00 price objective (up previously from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. Wall Street Zen raised HealthEquity from a “hold” rating to a “buy” rating in a report on Friday, June 6th. Finally, Bank of America lifted their price objective on HealthEquity from $110.00 to $125.00 and gave the stock a “buy” rating in a report on Wednesday, June 4th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $119.77.

HealthEquity Stock Down 6.4%

Shares of NASDAQ:HQY opened at $91.48 on Friday. The company has a market capitalization of $7.88 billion, a PE ratio of 55.44, a price-to-earnings-growth ratio of 1.42 and a beta of 0.50. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.06. The business has a fifty day moving average price of $94.37 and a two-hundred day moving average price of $95.11. HealthEquity has a 1 year low of $74.07 and a 1 year high of $116.65.

Insiders Place Their Bets

In other HealthEquity news, EVP Michael Henry Fiore sold 1,794 shares of HealthEquity stock in a transaction dated Monday, July 7th. The stock was sold at an average price of $101.73, for a total transaction of $182,503.62. Following the completion of the transaction, the executive vice president owned 53,225 shares of the company’s stock, valued at $5,414,579.25. The trade was a 3.26% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.50% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Wealth Enhancement Advisory Services LLC grew its holdings in HealthEquity by 24.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 6,380 shares of the company’s stock valued at $564,000 after buying an additional 1,265 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its holdings in HealthEquity by 7,983.6% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,655 shares of the company’s stock valued at $2,179,000 after buying an additional 24,350 shares in the last quarter. GAMMA Investing LLC grew its holdings in HealthEquity by 25.9% during the 1st quarter. GAMMA Investing LLC now owns 1,571 shares of the company’s stock valued at $139,000 after buying an additional 323 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in HealthEquity by 995.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company’s stock valued at $56,500,000 after buying an additional 580,988 shares in the last quarter. Finally, WCM Investment Management LLC purchased a new position in HealthEquity during the 1st quarter valued at about $20,230,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.